Citigroup Inc Teva Pharmaceutical Industries LTD Put Options Transaction History

Citigroup Inc

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$10.67 - $14.43 $66.4 Million - $89.8 Million	6,225,000 New	6,225,000 $87.8 Million
Q2 2023 Aug 10, 2023	SELL	$7.2 - $9.47 $67.1 Million - $88.2 Million	-9,316,200 Reduced 97.9%	200,000 $1.51 Million
Q1 2023 May 11, 2023	BUY	$8.36 - $11.37 $54.9 Million - $74.7 Million	6,568,900 Added 222.88%	9,516,200 $84.2 Million
Q4 2022 Feb 09, 2023	SELL	$7.95 - $9.48 $11.9 Million - $14.2 Million	-1,500,000 Reduced 33.73%	2,947,300 $26.9 Million
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $26.6 Million - $46.4 Million	-3,883,200 Reduced 46.61%	4,447,300 $35.9 Million

Q2 2022 Aug 10, 2022	SELL	$7.38 - $10.4 $7.86 Million - $11.1 Million	-1,064,900 Reduced 11.33%	8,330,500 $62.6 Million
Q1 2022 May 12, 2022	SELL	$7.33 - $9.39 $3.19 Million - $4.09 Million	-435,100 Reduced 4.43%	9,395,400 $88.2 Million
Q4 2021 Feb 10, 2022	BUY	$7.9 - $10.19 $73.7 Million - $95.1 Million	9,330,500 Added 1866.1%	9,830,500 $78.7 Million
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $4.19 Million - $5.09 Million	500,000 New	500,000 $4.87 Million

539

548M

19.8M

14M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.